2009-11-10 19:45:01 -
IRIS International, Inc. - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/iris-interna ..
IRIS International, Inc. (IRIS) designs, develops, manufactures and markets in-vitro diagnostic imaging products that analyze particles and living cell forms and structures, or morphology of a variety of body fluids. The company operates through two reportable business segments, namely, In-Vitro Diagnostics (IVD) and Sample Processing segment. In addition it also offers products in relation with cytology, hematology, and urinalysis for
the clinical and veterinary markets. It conducts its business operations through three operating subsidiaries namely Advanced Digital Imaging Research (ADIR), Iris Molecular Diagnostics (IMD) and IRIS Sample Processing.
The IRIS International, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
